EQUITY INVESTOR FUND BIOTECHNOLOGY PORT 2000 SERIES B DAF
C/O DAVIS POLK & WARDWELL, 450 LEXINGTON AVE, NEW YORK NY 10017
2000 SEC Filings
EQUITY INVESTOR FUND BIOTECHNOLOGY PORT 2000 SERIES B DAF, 497, 2000-05-22
EQUITY INVESTOR FUND BIOTECHNOLOGY PORT 2000 SERIES B DAF, 497, 2000-04-19
EQUITY INVESTOR FUND FOCUS SER BIOTECH PORT 2000 SER B DAF, 487, 2000-04-18
EQUITY INVESTOR FUND FOCUS SERIES 17 DEFINED ASSET FUNDS, S-6, 2000-02-01
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission
